Systemic isotretinoin in the management of acne – a patient questionnaire survey
Background: The primary aim was to investigate the appropriateness (as outlined in the South African Acne Treatment Guideline 1) for the prescription of systemic isotretinoin in the management and counselling of acne in the Nelson Mandela Bay Metropole. Methods: A questionnaire was distributed to...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2009-10-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849234055795572736 |
|---|---|
| author | Solé Burger Ilse Truter Suzette M. Blignault Danie J.L. Venter |
| author_facet | Solé Burger Ilse Truter Suzette M. Blignault Danie J.L. Venter |
| author_sort | Solé Burger |
| collection | DOAJ |
| description | Background: The primary aim was to investigate the appropriateness (as outlined in the South African Acne Treatment Guideline 1) for the prescription of systemic isotretinoin in the management and counselling of acne in the Nelson Mandela Bay Metropole.
Methods: A questionnaire was distributed to patients receiving systemic isotretinoin by 30 community pharmacies. The response rate was 29.2% (57 respondents).
Results: The acne medication history revealed that commercial brands of beauty products were used by 57.9% of respondents, topical benzoyl peroxide by 22.8%, and systemic cotrimoxazole by 19.3%. Only nine females used an oral contraceptive as acne treatment prior to isotretinoin. The average daily dose of isotretinoin was 44.2 (SD=16.9) mg. Half of the respondents received a suboptimal cumulative dosage of isotretinoin. The average prescribed duration of isotretinoin therapy was 6.2 months. Adequate counselling was received by only 57.9% of patients. A third of the patients who were able to fall pregnant received recommendations for contraception. Pregnancy tests were conducted in only two females. Just over 40% of patients reported a complete clearance of acne lesions.
Conclusions: Many prescribers did not follow the recommendations for isotretinoin prescription. The counselling of patients regarding isotretinoin therapy was substandard, especially with respect to pregnancy prevention. |
| format | Article |
| id | doaj-art-ec036470c8534b6487e0cfecff647c7f |
| institution | Kabale University |
| issn | 2078-6190 2078-6204 |
| language | English |
| publishDate | 2009-10-01 |
| publisher | AOSIS |
| record_format | Article |
| series | South African Family Practice |
| spelling | doaj-art-ec036470c8534b6487e0cfecff647c7f2025-08-20T04:03:17ZengAOSISSouth African Family Practice2078-61902078-62042009-10-0151510.1080/20786204.2009.108738971093Systemic isotretinoin in the management of acne – a patient questionnaire surveySolé Burger0Ilse Truter1Suzette M. Blignault2Danie J.L. Venter3Drug Utilization Research Unit, Department of Pharmacy, Nelson Mandela Metropolitan UniversityDrug Utilization Research Unit, Department of Pharmacy, Nelson Mandela Metropolitan UniversityDrug Utilization Research Unit, Department of Pharmacy, Nelson Mandela Metropolitan UniversityDepartment of Statistics, Nelson Mandela Metropolitan UniversityBackground: The primary aim was to investigate the appropriateness (as outlined in the South African Acne Treatment Guideline 1) for the prescription of systemic isotretinoin in the management and counselling of acne in the Nelson Mandela Bay Metropole. Methods: A questionnaire was distributed to patients receiving systemic isotretinoin by 30 community pharmacies. The response rate was 29.2% (57 respondents). Results: The acne medication history revealed that commercial brands of beauty products were used by 57.9% of respondents, topical benzoyl peroxide by 22.8%, and systemic cotrimoxazole by 19.3%. Only nine females used an oral contraceptive as acne treatment prior to isotretinoin. The average daily dose of isotretinoin was 44.2 (SD=16.9) mg. Half of the respondents received a suboptimal cumulative dosage of isotretinoin. The average prescribed duration of isotretinoin therapy was 6.2 months. Adequate counselling was received by only 57.9% of patients. A third of the patients who were able to fall pregnant received recommendations for contraception. Pregnancy tests were conducted in only two females. Just over 40% of patients reported a complete clearance of acne lesions. Conclusions: Many prescribers did not follow the recommendations for isotretinoin prescription. The counselling of patients regarding isotretinoin therapy was substandard, especially with respect to pregnancy prevention.https://safpj.co.za/index.php/safpj/article/view/1310acneisotretinoinskin conditionsdrug utilisationquestionnaire surveydermatology |
| spellingShingle | Solé Burger Ilse Truter Suzette M. Blignault Danie J.L. Venter Systemic isotretinoin in the management of acne – a patient questionnaire survey South African Family Practice acne isotretinoin skin conditions drug utilisation questionnaire survey dermatology |
| title | Systemic isotretinoin in the management of acne – a patient questionnaire survey |
| title_full | Systemic isotretinoin in the management of acne – a patient questionnaire survey |
| title_fullStr | Systemic isotretinoin in the management of acne – a patient questionnaire survey |
| title_full_unstemmed | Systemic isotretinoin in the management of acne – a patient questionnaire survey |
| title_short | Systemic isotretinoin in the management of acne – a patient questionnaire survey |
| title_sort | systemic isotretinoin in the management of acne a patient questionnaire survey |
| topic | acne isotretinoin skin conditions drug utilisation questionnaire survey dermatology |
| url | https://safpj.co.za/index.php/safpj/article/view/1310 |
| work_keys_str_mv | AT soleburger systemicisotretinoininthemanagementofacneapatientquestionnairesurvey AT ilsetruter systemicisotretinoininthemanagementofacneapatientquestionnairesurvey AT suzettemblignault systemicisotretinoininthemanagementofacneapatientquestionnairesurvey AT daniejlventer systemicisotretinoininthemanagementofacneapatientquestionnairesurvey |